ArticleCureus2026
Impact of Clinical Pharmacist Interventions on Medication Safety and Therapy Optimization in a Tertiary Care Hospital.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Medication-related problems remain a significant concern in hospital-based care, particularly in critically ill and pediatric populations where pharmacotherapy is complex and frequently modified. Clinical pharmacist-led medication review may improve medication safety through structured identification of therapy-related issues. Methodology This retrospective quality improvement evaluation analyzed structured inpatient medication review encounters conducted over a 14-month period at a tertiary care hospital. Intervention frequency, category distribution, and prescriber acceptance were assessed. Descriptive statistics were calculated, and chi-square testing was performed to evaluate associations between intervention category and acceptance status. Results Over 5,800 medication review encounters resulted in 2,441 clinical interventions. Dose optimization constituted the largest intervention category. The overall acceptance rate was 2,212 (90.6%). A statistically significant association was observed between intervention category and acceptance status (χ² = 46.46, df = 5, p < 0.001). Conclusions Structured clinical pharmacist involvement resulted in frequent and widely accepted interventions during inpatient medication review. Significant variability in acceptance patterns across intervention categories supports the clinical integration of pharmacist services within tertiary care hospital settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.